SPEAKERS
Mark A. Bach
Vice President, Office of the Chief Medical Officer, Johnson & Johnson
Saturday 7, December
- PROGRAM
-
10:00-17:30
Parallel Session 3
PROFILE
Mark is currently Vice President, Office of the Chief Medical Officer, Johnson and Johnson, where he is leading a project to develop a cloud-based solution to transform the way in which pharmaceutical companies and regulatory authorities exchange information and interact.
Mark joined Janssen in 2010 as Vice President and Head of Japan R&D, and from 2012 until August 2019 he led Janssen‘s Asia Pacific Medical Sciences organization, a team of over 1,400 science professionals in Drug Discovery and Clinical Development. From 2015 he took on an additional role leading Janssen’s R&D and Medical Affairs team in China. Mark has focused on building organizational capabilities and eliminating ‘drug lag’ to bring important new medicines to patients in need across the region.
Mark joined the pharmaceutical industry in 1993 with Merck & Co. (MSD), where he held positions of increasing responsibility in global, regional and Japan-based roles over 16 years.
Mark received his Ph.D. in Pathology from the University of Chicago and his medical degree from the Baylor College of Medicine, where he also served his residency in pediatrics. He was trained as a Pediatric Endocrinologist at the U.S. National Institutes of Health.
Mark joined Janssen in 2010 as Vice President and Head of Japan R&D, and from 2012 until August 2019 he led Janssen‘s Asia Pacific Medical Sciences organization, a team of over 1,400 science professionals in Drug Discovery and Clinical Development. From 2015 he took on an additional role leading Janssen’s R&D and Medical Affairs team in China. Mark has focused on building organizational capabilities and eliminating ‘drug lag’ to bring important new medicines to patients in need across the region.
Mark joined the pharmaceutical industry in 1993 with Merck & Co. (MSD), where he held positions of increasing responsibility in global, regional and Japan-based roles over 16 years.
Mark received his Ph.D. in Pathology from the University of Chicago and his medical degree from the Baylor College of Medicine, where he also served his residency in pediatrics. He was trained as a Pediatric Endocrinologist at the U.S. National Institutes of Health.
